A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
|Articles|June 8, 2016
Vaccinations: What parents want (VIDEO)
Author(s)Bobby Lazzara, MD
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a nationally representative survey published in Clinical Pediatrics. The survey asked parents what they wanted to know about vaccines and how they wanted providers to handle their concerns.
Advertisement
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a nationally representative survey published in Clinical Pediatrics. The survey asked parents what they wanted to know about vaccines and how they wanted providers to handle their concerns.
Advertisement
Related to this article
New real-world data reveal delays and disparities in nirsevimab administration, highlighting opportunities to improve timely RSV protection for infants.
CDC confirmed the first pediatric flu death of 2026-27, linked to H1N1, as early flu activity rises in 2026.
With California WNV activity at a 5-year high, CHLA outlines age-based repellent and bite-prevention guidance for children.
Johanna Chang, MD, offers guidance on vaccination, infection prophylaxis, and clinical warning signs in children receiving biologic therapies.
Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.
Todd Wolynn, MD, MMM, FAAP, explains how pediatricians can address misinformation through empathetic communication and community engagement.
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Advertisement
Advertisement